Friday, April 15, 2016

Molecular Therapy - Table of Contents alert Volume 24 Issue 4

If you are unable to see the message below, click here to view.
Molecular Therapy

TABLE OF CONTENTS

Volume 24, Issue 4 (April 2016)

In this issue
Editorial
In This Issue
Research Highlights
Letter to the Editor
Commentaries
Addenda to Genome Editing Special Issue
Addenda to Genome Editing Special Issue
Review
Original Articles
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorial

Top

Expanded Opportunities for Methods and Clinical Development

Roland W Herzog

Mol Ther 2016 24: 655-656; 10.1038/mt.2016.44

Full Text

In This Issue

Top

In This Issue

Mol Ther 2016 24: 658; 10.1038/mt.2016.45

Full Text

Research Highlights

Top

Research Highlights

Mol Ther 2016 24: 659; 10.1038/mt.2016.46

Full Text

Letter to the Editor

Top

Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV

Jean-Charles Nault, Iadh Mami, Tiziana La Bella, Shalini Datta, Sandrine Imbeaud, Andrea Franconi, Maxime Mallet, Gabrielle Couchy, Eric Letouzé, Camilla Pilati, Benjamin Verret, Jean-Frédéric Blanc, Charles Balabaud, Julien Calderaro, Alexis Laurent, Mélanie Letexier, Paulette Bioulac-Sage, Fabien Calvo and Jessica Zucman-Rossi

Mol Ther 2016 24: 660-661; 10.1038/mt.2016.47

Full Text

Reply to “Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV”

Manfred Schmidt, Irene Gil-Farina and Hildegard Büning

Mol Ther 2016 24: 661-662; 10.1038/mt.2016.48

Full Text

Commentaries

Top

AAVR: A Multi-Serotype Receptor for AAV

Candace Summerford and R. Jude Samulski

Mol Ther 2016 24: 663-666; 10.1038/mt.2016.49

Full Text

siRNA Therapeutics for Primary Hyperoxaluria: A Beginning

Dawn S Milliner

Mol Ther 2016 24: 666-667; 10.1038/mt.2016.50

Full Text

Gene Therapy for Hemoglobinopathies: Tremendous Successes and Remaining Caveats

Punam Malik

Mol Ther 2016 24: 668-670; 10.1038/mt.2016.57

Full Text

Addenda to Genome Editing Special Issue

Top

Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus

Abdullah Ely, Buhle Moyo and Patrick Arbuthnot

Mol Ther 2016 24: 671-677; advance online publication, February 26, 2016; 10.1038/mt.2016.43

Abstract | Full Text

Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy

Eirini P Papapetrou and Axel Schambach

Mol Ther 2016 24: 678-684; advance online publication, February 12, 2016; 10.1038/mt.2016.38

Abstract | Full Text

Addenda to Genome Editing Special Issue

Top

Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy

Soeren Turan, Alfonso P Farruggio, Waracharee Srifa, John W Day and Michele P Calos

Mol Ther 2016 24: 685-696; advance online publication, February 26, 2016; 10.1038/mt.2016.40

Abstract | Full Text

In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA

Dustin J Landau, Elizabeth Drake Brooks, Pablo Perez-Pinera, Hiruni Amarasekara, Adam Mefferd, Songtao Li, Andrew Bird, Charles A Gersbach and Dwight D Koeberl

Mol Ther 2016 24: 697-706; advance online publication, February 11, 2016; 10.1038/mt.2016.35

Abstract | Full Text

Review

Top

Modulation of Protein–Protein Interactions for the Development of Novel TherapeuticsMTOPEN

Ioanna Petta, Sam Lievens, Claude Libert, Jan Tavernier and Karolien De Bosscher

Mol Ther 2016 24: 707-718; advance online publication, December 17, 2015; 10.1038/mt.2015.214

Abstract | Full Text

Original Articles

Top

Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I

Cristina Martin-Higueras, Sergio Luis-Lima and Eduardo Salido

Mol Ther 2016 24: 719-725; advance online publication, December 22, 2015; 10.1038/mt.2015.224

Abstract | Full Text

Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector

Sourav R Choudhury, Anne F Harris, Damien J Cabral, Allison M Keeler, Ellen Sapp, Jennifer S Ferreira, Heather L Gray-Edwards, Jacob A Johnson, Aime K Johnson, Qin Su, Lorelei Stoica, Marian DiFiglia, Neil Aronin, Douglas R Martin, Guangping Gao and Miguel Sena-Esteves

Mol Ther 2016 24: 726-735; advance online publication, December 28, 2015; 10.1038/mt.2015.231

Abstract | Full Text

Clonal Dynamics In Vivo of Virus Integration Sites of T Cells Expressing a Safety Switch

Edmund C Chang, Hao Liu, John A West, Xiaoou Zhou, Olga Dakhova, David A Wheeler, Helen E Heslop, Malcolm K Brenner and Gianpietro Dotti

Mol Ther 2016 24: 736-745; advance online publication, December 7, 2015; 10.1038/mt.2015.217

Abstract | Full Text

Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders

Hayate Javed, Sindhu A Menon, Karima M Al-Mansoori, Abdelmojib Al-Wandi, Nour K Majbour, Mustafa T Ardah, Shiji Varghese, Nishant N Vaikath, M Emdadul Haque, Mimoun Azzouz and Omar MA El-Agnaf

Mol Ther 2016 24: 746-758; advance online publication, December 24, 2015; 10.1038/mt.2015.232

Abstract | Full Text

Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles

Meghna Talekar, Malav Trivedi, Parin Shah, Qijun Ouyang, Adwait Oka, Srujan Gandham and Mansoor M Amiji

Mol Ther 2016 24: 759-769; advance online publication, December 21, 2015; 10.1038/mt.2015.225

Abstract | Full Text

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1MTOPEN

Chaitali Dutta, Nicole Avitahl-Curtis, Natalie Pursell, Marita Larsson Cohen, Benjamin Holmes, Rohan Diwanji, Wei Zhou, Luciano Apponi, Martin Koser, Bo Ying, Dongyu Chen, Xue Shui, Utsav Saxena, Wendy A Cyr, Anee Shah, Naim Nazef, Weimin Wang, Marc Abrams, Henryk Dudek, Eduardo Salido, Bob D Brown and Chengjung Lai

Mol Ther 2016 24: 770-778; advance online publication, January 13, 2016; 10.1038/mt.2016.4

Abstract | Full Text

Smooth Muscle Cell–targeted RNA Aptamer Inhibits Neointimal Formation

William H Thiel, Carla L Esposito, David D Dickey, Justin P Dassie, Matthew E Long, Joshua Adam, Jennifer Streeter, Brandon Schickling, Maysam Takapoo, Katie S Flenker, Julia Klesney-Tait, Vittorio de Franciscis, Francis J Miller, Jr and Paloma H Giangrande

Mol Ther 2016 24: 779-787; advance online publication, January 6, 2016; 10.1038/mt.2015.235

Abstract | Full Text

Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells

Yusuke Sato, Hiroto Hatakeyama, Mamoru Hyodo and Hideyoshi Harashima

Mol Ther 2016 24: 788-795; advance online publication, December 18, 2015; 10.1038/mt.2015.222

Abstract | Full Text

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth

Alison Tedcastle, Sam Illingworth, Alice Brown, Leonard W Seymour and Kerry D Fisher

Mol Ther 2016 24: 796-804; advance online publication, December 28, 2015; 10.1038/mt.2015.233

Abstract | Full Text

Human Mesenchymal Stem Cell Delivery System Modulates Ischemic Cardiac Remodeling With an Increase of Coronary Artery Blood Flow

Young Sook Lee, Wan Seok Joo, Hyun Soo Kim and Sung Wan Kim

Mol Ther 2016 24: 805-811; advance online publication, January 19, 2016; 10.1038/mt.2016.22

Abstract | Full Text

Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCsMTOPEN

Magdalena Laugsch, Maria Rostovskaya, Sergiy Velychko, Cornelia Richter, Ariane Zimmer, Barbara Klink, Evelin Schröck, Michael Haase, Katrin Neumann, Sebastian Thieme, Joachim Roesler, Sebastian Brenner and Konstantinos Anastassiadis

Mol Ther 2016 24: 812-822; advance online publication, August 28, 2015; 10.1038/mt.2015.154

Abstract | Full Text

Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell Transplantation

Xiaoou Zhou, Swati Naik, Olga Dakhova, Gianpietro Dotti, Helen E. Heslop and Malcolm K. Brenner

Mol Ther 2016 24: 823-831; advance online publication, December 28, 2015; 10.1038/mt.2015.234

Abstract | Full Text

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

Beatrice Ondondo, Hayato Murakoshi, Genevieve Clutton, Sultan Abdul-Jawad, Edmund G-T Wee, Hiroyuki Gatanaga, Shinichi Oka, Andrew J McMichael, Masafumi Takiguchi, Bette Korber and Tomáš Hanke

Mol Ther 2016 24: 832-842; advance online publication, January 8, 2016; 10.1038/mt.2016.3

Abstract | Full Text

Corrigendum

Top

Corrigendum to “Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders”

Mol Ther 2016 24: 843; 10.1038/mt.2016.58

Full Text

Corrigendum to “PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries”

Mol Ther 2016 24: 843; 10.1038/mt.2016.59

Full Text

Advertisement
Open for Submissions

Molecular Therapy — Oncolytics is an online-only, open access journal, focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.

Explore the benefits of submitting your next research article.

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: